Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diabetes Distress, Intentional Hyperglycemia at Work, and Glycemic Control Among Workers With Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of Dapagliflozin, Metformin or Exercise on Glucose Metabolism in Individuals with Prediabetes: The PRE-D Trial

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  2. Effects of Dapagliflozin, Metformin or Exercise on Markers of Cardiometabolic Risk: The PRE-D Trial

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Fat catch-up Growth in early infancy and cardiometabolic outcomes at 5 years of age

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. National trends in the use of lipid-lowering drugs among type 2 diabetes patients in Denmark from 1997 to 2017

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

OBJECTIVE: Type 1 diabetes is a complex disease, and development of multiple complications over time can be analyzed only with advanced statistical methods. This study describes the development of microvascular complications and explores the effect of complication burden and important concurrent risk factors by applying a multistate model.

RESEARCH DESIGN AND METHODS: We used a clinical cohort at the Steno Diabetes Center Copenhagen to study the development of diabetic kidney disease, retinopathy, and neuropathy. We extracted information from electronic patient records and estimated incidence rates of complications by concurrent complication burden. We explored the extent to which concurrent complications modify the effect of selected risk factors on the development of microvascular complications.

RESULTS: We included 3,586 individuals. Incidence rate ratios in individuals with two previous complications were 3.2 (95% CI 2.3-4.5) for diabetic kidney disease, 2.1 (1.5-3.1) for retinopathy, and 1.7 (1.2-2.4) for neuropathy compared with individuals without complications. The models included diabetes duration; calendar time and age as timescales; and sex, HbA1c, lipid-lowering and antihypertensive treatment, systolic blood pressure, BMI, estimated glomerular filtration rate (eGFR), cardiovascular disease (CVD), LDL cholesterol, insulin dose (units/kg/day), and smoking status as covariates. Effects of HbA1c, diabetes duration, systolic blood pressure, BMI, eGFR, and LDL cholesterol where not modified by concurrent complication burden, whereas the effect of sex and CVD were.

CONCLUSIONS: The risk of microvascular complications highly depends on the concurrent complication burden and risk factor profile in individuals with type 1 diabetes. The results emphasize attention to risk factors, regardless of existing number of complications, to prevent development of further microvascular complications.

Original languageEnglish
JournalDiabetes Care
Volume41
Issue number11
Pages (from-to)2297-2305
Number of pages8
ISSN1935-5548
DOIs
Publication statusPublished - Nov 2018

ID: 55045767